These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 1529781)
1. Biochemical properties of OR-1259--a positive inotropic and vasodilatory compound with an antiarrhythmic effect. Raasmaja A; Talo A; Haikala H; Nissinen E; Lindén IB; Pohto P Adv Exp Med Biol; 1992; 311():423. PubMed ID: 1529781 [No Abstract] [Full Text] [Related]
2. Levosimendan, a new inotropic and vasodilator agent. Toller WG; Stranz C Anesthesiology; 2006 Mar; 104(3):556-69. PubMed ID: 16508404 [TBL] [Abstract][Full Text] [Related]
3. The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan. Haikala H; Kaheinen P; Levijoki J; Lindén IB Cardiovasc Res; 1997 Jun; 34(3):536-46. PubMed ID: 9231037 [TBL] [Abstract][Full Text] [Related]
4. Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Hasenfuss G; Pieske B; Castell M; Kretschmann B; Maier LS; Just H Circulation; 1998 Nov; 98(20):2141-7. PubMed ID: 9815868 [TBL] [Abstract][Full Text] [Related]
5. Effects of Levosimendan, a cardiotonic agent targeted to troponin C, on cardiac function and on phosphorylation and Ca2+ sensitivity of cardiac myofibrils and sarcoplasmic reticulum in guinea pig heart. Edes I; Kiss E; Kitada Y; Powers FM; Papp JG; Kranias EG; Solaro RJ Circ Res; 1995 Jul; 77(1):107-13. PubMed ID: 7788868 [TBL] [Abstract][Full Text] [Related]
6. Calcium sensitization as new principle of inotropic therapy in end-stage heart failure? Zimmermann N; Boknik P; Gams E; Herzig JW; Neumann J; Scholz H Eur J Cardiothorac Surg; 1998 Jul; 14(1):70-5. PubMed ID: 9726618 [TBL] [Abstract][Full Text] [Related]
12. Investigation on SCH00013, a novel cardiotonic agent with Ca++ sensitizing action. 1st communication: phosphodiesterase III inhibitory effect and class III antiarrhythmic effect in guinea-pig heart. Hino M; Sugawara H; Yoshimura A; Ogura A; Yoshioka K; Sakato M; Endoh M Arzneimittelforschung; 1999 May; 49(5):398-406. PubMed ID: 10367101 [TBL] [Abstract][Full Text] [Related]
13. Cardiac responses to calcium sensitizers and isoproterenol in intact guinea pig hearts. Effects on cyclic AMP levels, protein phosphorylation, myoplasmic calcium concentration, and left ventricular function. Kristof E; Szigeti G; Papp Z; Bodi A; Facsko A; Kovacs L; Papp JG; Kranias EG; Edes I Ann N Y Acad Sci; 1998 Sep; 853():316-9. PubMed ID: 10603968 [No Abstract] [Full Text] [Related]
14. Cardiac electrophysiological effects of levosimendan, a new calcium sensitizer. Virág L; Hála O; Marton A; Varró A; Papp JG Gen Pharmacol; 1996 Apr; 27(3):551-6. PubMed ID: 8723543 [TBL] [Abstract][Full Text] [Related]
16. The effects of levosimendan on [Ca2+]i in guinea-pig isolated ventricular myocytes. Lancaster MK; Cook SJ Eur J Pharmacol; 1997 Nov; 339(1):97-100. PubMed ID: 9450621 [TBL] [Abstract][Full Text] [Related]
17. Two inotropes with different mechanisms of action: contractile, PDE-inhibitory and direct myofibrillar effects of levosimendan and enoximone. Szilágyi S; Pollesello P; Levijoki J; Haikala H; Bak I; Tósaki A; Borbély A; Edes I; Papp Z J Cardiovasc Pharmacol; 2005 Sep; 46(3):369-76. PubMed ID: 16116344 [TBL] [Abstract][Full Text] [Related]
18. A quantitative comparison of functional and anti-ischaemic effects of the phosphodiesterase-inhibitors, amrinone, milrinone and levosimendan in rabbit isolated hearts. Rump AF; Acar D; Klaus W Br J Pharmacol; 1994 Jul; 112(3):757-62. PubMed ID: 7921599 [TBL] [Abstract][Full Text] [Related]
19. [Calcium sensitizers--a new group of drugs that increase myocardium contractility]. Laine M; Lehtonen L; Nieminen MS Duodecim; 2000; 116(20):2181-3. PubMed ID: 12017622 [No Abstract] [Full Text] [Related]
20. Inotropic, vasodilating and preconditioning actions of levosimendan in the heart. Meyer K; Schipke JD; Klocke RC; Gams E; Korbmacher B Thorac Cardiovasc Surg; 2008 Oct; 56(7):379-85. PubMed ID: 18810693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]